The American pharmaceutical group Johnson & Johnson said on Tuesday that it had "made the decision to delay the deployment" of its single-dose vaccine against Covid-19 in Europe after the decision of the American health authorities to recommend "a pause" in its use in the USA.
The American pharmaceutical group Johnson & Johnson said on Tuesday that it had "made the decision to delay the deployment" of its single-dose vaccine against Covid-19 in Europe after the decision of the American health authorities to recommend "a pause" in its use in the USA.
>> LIVE -
Coronavirus: follow the evolution of the situation Tuesday, April 13
The country's main federal public health agencies want to investigate six cases of people who developed severe cases of blood clots after receiving the vaccine in the country.
Johnson & Johnson "is studying these cases with European health authorities," the group said in a message to AFP.
The vaccine break will in any case "not have a significant impact" on the American vaccination campaign, according to the White House.